Global G-CSF (Granulocyte Colony Stimulating Factors) Market Value Expected To Reach $8.33 Billion By 2023

AB Newswire is committed to help every business gain greater visibility via Press Release writing and distribution. On October 28, 2020, it released an article on the G-CSF market, sourced from TBRC`s Global Granulocyte Colony Stimulating Factors Market report. The global G-CSF market covers Lenograstim (Granocyte), Filgrastim (Neupogen, Zarzio, Nivestim, Accofil), Long acting (pegylated) filgrastim (pegfilgrastim, Neulasta, Pelmeg, Ziextenco), Lipegfilgrastim (Lonquex).